GAS5 and inflammatory bowel disease: Considering the impact of IBD type on GAS5-AS1 levels, a statistically significant downregulation in inflamed mucosa compared to non-inflamed one was observed only for UC patients (t-test p = 0.018) but not for CD (t-test p = 0.629), where however a trend was still present.